International Drug Alerts: COX-2 Inhibitors and Co-proxamol

The European Union has restricted the use of celecoxib (Celebrex), valdecoxib (Bextra), parecoxib (Dynastat), lumiracoxib (Prexige), and etoricoxib (Arcoxia) in the European Union; the United Kingdom has approved the gradual withdrawal of a paracetamol plus dextropropoxyphene product (Co-proxamol) from the market.Yael Waknine

Continue to International Drug Alerts: COX-2 Inhibitors and Co-proxamol on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz